UVLRX THERAPEUTICS INTRAVENOUS LIGHT THERAPY Trademark

Trademark Overview

On Tuesday, June 21, 2016, a trademark application was filed for UVLRX THERAPEUTICS INTRAVENOUS LIGHT THERAPY with the United States Patent and Trademark Office. The USPTO has given the UVLRX THERAPEUTICS INTRAVENOUS LIGHT THERAPY trademark a serial number of 87079460. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 2, 2019. This trademark is owned by UVLRX THERAPEUTICS, INC.. The UVLRX THERAPEUTICS INTRAVENOUS LIGHT THERAPY trademark is filed in the Medical Instrument Products category with the following description:

Medical devices, namely, intravenous blood irradiation devices that use radiation for treatment of blood to modulate the immune system, reduce pathogens, reduce inflammation, increase adenosine triphosphate (ATP) synthesis and improve hemodynamics and blood oxygen transport, reduce pain and improve wound healing
uvlrx therapeutics intravenous light therapy

General Information

Serial Number87079460
Word MarkUVLRX THERAPEUTICS INTRAVENOUS LIGHT THERAPY
Filing DateTuesday, June 21, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 2, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 5, 2017

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"UVL", "THERAPEUTICS" AND "INTRAVENOUS LIGHT THERAPY"
Description of MarkThe mark consists of "UVLRX" where the "RX" appears in smaller font above the lower portion of the letter "L" above the word "THERAPEUTICS" which is above a rectangle containing the words "INTRAVENOUS LIGHT THERAPY".
Goods and ServicesMedical devices, namely, intravenous blood irradiation devices that use radiation for treatment of blood to modulate the immune system, reduce pathogens, reduce inflammation, increase adenosine triphosphate (ATP) synthesis and improve hemodynamics and blood oxygen transport, reduce pain and improve wound healing
Pseudo MarkUVL RX THERAPEUTICS INTRAVENOUS LIGHT THERAPY

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, June 27, 2016
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePBMSG, LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressTAMPA, FL 33602
Party NameUVLRX THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOldsmar, FL 34677
Party NameUVLRX THERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSanta Barbara, CA 93101

Trademark Events

Event DateEvent Description
Wednesday, September 22, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, September 3, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 2, 2019ABANDONMENT - NO USE STATEMENT FILED
Wednesday, April 17, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 16, 2019EXTENSION 2 GRANTED
Wednesday, January 30, 2019EXTENSION 2 FILED
Tuesday, April 16, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 20, 2019NOTICE OF REVIVAL - E-MAILED
Tuesday, March 19, 2019EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, March 19, 2019PETITION TO REVIVE-GRANTED
Tuesday, March 19, 2019TEAS PETITION TO REVIVE RECEIVED
Monday, March 11, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 11, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 4, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 4, 2019ABANDONMENT - NO USE STATEMENT FILED
Wednesday, August 1, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 30, 2018EXTENSION 1 GRANTED
Monday, July 30, 2018EXTENSION 1 FILED
Monday, July 30, 2018TEAS EXTENSION RECEIVED
Tuesday, January 30, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 5, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 5, 2017PUBLISHED FOR OPPOSITION
Wednesday, November 15, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 23, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 23, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 23, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 18, 2017ASSIGNED TO LIE
Thursday, October 5, 2017TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, April 5, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, April 5, 2017FINAL REFUSAL E-MAILED
Wednesday, April 5, 2017FINAL REFUSAL WRITTEN
Friday, March 31, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 30, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 30, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 30, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 30, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 30, 2016NON-FINAL ACTION E-MAILED
Friday, September 30, 2016NON-FINAL ACTION WRITTEN
Tuesday, September 27, 2016ASSIGNED TO EXAMINER
Tuesday, June 28, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, June 27, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, June 24, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

therapy light intravenous therapeutics uvlrx blood reduce improve devices synthesis triphosphate adenosine hemodynamics transport healing